Want to join the conversation?
$LLL expects book-to-bill ratio for 2015 to be approx. 0.97. This is due to the lower expected international and commercial orders, which will impact 2016 sales. For 2016, consolidated sales is expected to decline about 3% to $11.1Bil. This estimate assumes an organic sales decline of about 1.5%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.